World faces risk of 'vaccine nationalism' in COVID-19 fight, says CEPI chair

It's a problem Jane Halton, a former WHO board member, calls 'vaccine nationalism.' 'I worry that some countries will see that there is strategic advantage in the use of any developed vaccine, if they are successful. I also think that there is, in some cases, a need to deal with domestic concerns,' Halton said. 'And I understand that being able to balance a need for domestic distribution, particularly for the vulnerable, but at the same time acknowledging that all countries are in this together — I think there's a middle line to be struck here.' Halton, who is chair of the Coalition for Epidemic Preparedness Innovations and former head of Australia’s health and finance departments, tells The World's host Marco Werman that vaccine production should be globally distributed and initially target the most vulnerable in all nations.